Macau’s first biopharma firm lists in Hong Kong via Hengqin launchpad
Guangdong True Health became the first Macau-linked biopharma company to list publicly, debuting on the Hong Kong Stock Exchange The surgical robotics firm raised HK$384 million (USD49.23 million), marking the first public exit for a company cultivated by the Macau-Hengqin integrated development zone Guangdong True Health Medical Technology Development Co., Ltd. began trading on Hong…